Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treatment guidelines for endometrial cancer and increased rates of incidence

Prof John Green - University of Liverpool, UK
Treatment guidelines for endometrial cancer and increased rates of incidence ( Prof John Green - University of Liverpool, UK )
31 Oct 2013

Fertility preserving surgical treatment methods in young women

Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany
Fertility preserving surgical treatment methods in young women ( Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany )
31 Oct 2013

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology
European Cancer Congress 2013 - News Roundup ( Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology )
22 Oct 2013

Meeting highlights from the 11th iwNHL 2013: Day 2

Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh
Meeting highlights from the 11th iwNHL 2013: Day 2 ( Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh )
15 Oct 2013

Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan

Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan ( Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan )
7 Oct 2013

FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA )
7 Oct 2013

Androgen blockade and ipilimumab against castration resistant prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Paris, France
Androgen blockade and ipilimumab against castration resistant prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Paris, France )
3 Oct 2013

Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer

Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK
Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer ( Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK )
30 Sep 2013

ecancerNews Highlights from August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews Highlights from August 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Aug 2013

Treatment of granulomatous mastitis

Dr Alajmi Adil Aljarrah - Sultan Qaboos University Hospital, Muscat, Sultanate of Oman
Treatment of granulomatous mastitis ( Dr Alajmi Adil Aljarrah - Sultan Qaboos University Hospital, Muscat, Sultanate of Oman )
25 Jul 2013

Role of metronomics in cancer clinical trials and practice in developing countries

Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India
Role of metronomics in cancer clinical trials and practice in developing countries ( Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India )
19 Jul 2013

Improving predictability of clinical trial outcomes

Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving predictability of clinical trial outcomes ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
18 Jul 2013